Application of Acoustic Ejection MS System to High-Throughput Screening for SARS-CoV-2 3CL Protease Inhibitors

Chem Pharm Bull (Tokyo). 2022 Mar 1;70(3):199-201. doi: 10.1248/cpb.c21-01003. Epub 2021 Dec 21.

Abstract

MS is a powerful methodology for chemical screening to directly quantify substrates and products of enzymes, but its low throughput has been an issue. Recently, an acoustic liquid-handling apparatus (Echo®) used for rapid nano-dispensing has been coupled to a high-sensitivity mass spectrometer to create the Echo® MS system, and we applied this system to screening of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3CL protease inhibitors. Primary screening of 32033 chemical samples was completed in 12 h. Among the hits showing selective, dose-dependent 3CL-inhibitory activity, 8 compounds showed antiviral activity in cell-based assay.

Keywords: acoustic ejection MS; high-throughput screening; label-free; main protease; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3CL protease.

MeSH terms

  • Acoustics
  • COVID-19 Drug Treatment*
  • High-Throughput Screening Assays / methods
  • Humans
  • Protease Inhibitors* / chemistry
  • Protease Inhibitors* / pharmacology
  • SARS-CoV-2

Substances

  • Protease Inhibitors